Stem Cell Breakthrough Helps 85% Of Type 2 Diabetes Patients
A study carried out in Argentina by a team of researchers from a Not-For-Profit Organization called ‘Don Roberto Fernandez Viña Foundation’ (San Nicolas- Buenos Aires, Argentina) demonstrated that stem cells implanted into type 2 diabetes patients, in direct form into the pancreas, improve the production of Endogenous Insulin, increase the levels of “C Peptide”, decrease blood glucose levels and glycated hemoglobin levels faster than other treatments.
Infant Transplant Patients Resist Infections that Kill Adult AIDS Patients
This discovery indicates a hidden safety net that might have far-reaching consequences for treating diseases of the immune system such as AIDS.
Gene Therapy Offers New Hope For Heart Patients
Gene therapy research going on in Colorado is showing promising results for new treatments of severe heart disease. The new technique being tested at the Medical Center of Aurora is offering hope to people who can’t be helped by standard treatments like by-pass or angioplasty.
‘I Now Have A Face’ Says Face Transplant Recipient
Isabelle Dinoire, the first person to receive a face transplant, said ‘I now have a face like everyone else’ in her first news conference held today in Amiens, France.
Testing Stem Cells For Peripheral Artery Disease – Indiana University School Of Medicine Has Begun Unique Clinical Trial
Indiana University School of Medicine scientists have begun a unique clinical trial using stem cell injections as a treatment that could offer hope to tens of thousands of people who face sores, ulcers and even amputations due to severe peripheral artery disease.
Edinburgh Scientists Identify A Key Player In Making Specialised Cells From Embryonic Stem Cells
Scientists from the University of Edinburgh have shown that the protein Mbd3 plays a crucial role in the process by which embryonic stem cells become specialised cells, such as brain or skin cells.
The International Stem Cell Forum Welcomes California Institute for Regenerative Medicine
The International Stem Cell Forum (ISCF) announced at its annual meeting that the California Institute for Regenerative Medicine (CIRM) has been invited to join.
Scientists Force Viruses to Evolve as Better Delivery Vehicles for Gene Therapy
UC Berkeley’s David Schaffer, associate professor of chemical engineering and a member of the Helen Wills Neuroscience Institute, with colleagues Narendra Maheshri, James T. Koerber and Brian Kaspar, decided to speed up the process of viral evolution and direct the change in a way that would allow the virus to slip past the body’s immune defenses, making it a more viable vehicle for gene therapy.
ABSTRACT, REVIEWS, & SPECIAL REPORTS
A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells
Thus, macrophages and DCs appear to renew from a common progenitor, providing a cellular and molecular basis for the concept of the MPS.
Gastrointestinal Stem Cells. III. Emergent Themes of Liver Stem Cell Biology: Niche, Quiescence, Self-renewal, and Plasticity
This essay will address areas of liver stem/progenitor cell studies in which consensus has emerged and in which controversy still prevails over consensus, but it will also highlight important themes that inevitably should be a focus of liver stem/progenitor cell investigations in coming years.
Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma
Immunization produced T-cell responses in all patients with evidence of tumor stabilization in 2 of the 10 advanced cancer patients treated. These data support further clinical evaluation of this dendritic cell-MFP immunotherapy.